SCHEMBL6977421

SCHEMBL6977421

CC#C/C(C)=N\OC[C@H]1CCCN1CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9975258 0.85 HRH3 (0.31) —
SCHEMBL6979681 0.85 HRH3 (0.31) —
SCHEMBL6959693 0.84 — —
SCHEMBL6959791 0.84 — —
SCHEMBL15304846 0.81 LTA4H (0.39) —
SCHEMBL6959695 0.69 L3MBTL1 (0.38) —
SCHEMBL15304819 0.68 — —
SCHEMBL6958274 0.68 CHRM3 (0.30) —
SCHEMBL6959114 0.68 CHRM3 (0.30) —
SCHEMBL3895146 0.67 POLB (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349857-B2 Quinazoline derivatives having tyrosine kinase inhibitory activity SHIONOGI & CO., LTD. (JP) 2013-01-08 — — US disclosed
US-20120123114-A1 QUINAZOLINE DERIVATIVES HAVING TYROSINE KINASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2012-05-17 — — US disclosed
Send feedback